ASCVD & residual risk: recent clinical insights with icosapent ethyl.

26 August 2022 (15:35 - 15:45)
Organised by:
Congress Presentation Part of: New frontiers in ASCVD risk reduction: integrating icosapent ethyl in clinical practice Lipid-Lowering Agents Open Access ESC Congress 2022

About the speaker

Photo

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

4 More presentations in this session

The Event

Event poster

ESC Congress 2022

26 August 2022 15:35 CET
You may be interested in